Qin Yang

Qin Yang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2026 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
JKJuanjuan Kang
Juanjuan Kang
RHRong Huang
Rong Huang
YCYumei Chen
Yumei Chen
YYYang Yu
Yang Yu
XLXinyu Li
Xinyu Li
QYQin Yang
Qin Yang
Background: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but frequently induce immune-related adverse events (irAEs), which can disrupt treatment and worsen outcomes. The mechanisms predisposing certain individuals to irAEs remain unclear, and reliable strategies for early prediction and prevention are urgently needed. Methods: We analyzed pre-treatment peripheral blood mononuclear cell (PBMC) transcriptomic data from 88 patients receiving ICIs, including 22 who subsequently developed irAEs. Immune infiltration signatures were used to build machine learning models with SHAP-based interpretability. Immune-related differentially expressed genes were then incorporated into the Chemical-Induced Gene Signature (CIGS) framework to predict candidate reversal compounds. Selected compounds were further evaluated in Jurkat T cells to experimentally validate their effects on interferon-γ signaling and underlying mechanisms. Results: Baseline immune infiltration patterns showed strong predictive value for subsequent irAE development, with the Random Forest model achieving the best performance (AUC = 0.97). SHAP analysis revealed that activated T-cell and NK-cell signatures were dominant predictors, indicating a pre-existing immune-primed state in irAE-prone individuals. Single-cell analysis identified two irAE-enriched myeloid clusters with lung-associated inflammatory features, suggesting baseline myeloid priming. T cells and NK cells from irAE samples exhibited marked upregulation of interferon-stimulated genes and strong enrichment of type I and type II interferon pathways. Perturbation-based screening identified multiple compounds capable of reversing these interferon-amplified signatures, and in vitro experiments demonstrated that alpinetin and momelotinib suppress interferon-γ signaling through distinct STAT1-and JAK–STAT–dependent mechanisms. Conclusion: irAEs may arise from the convergence of pre-existing myeloid inflammation and interferon-driven lymphocyte activation before therapy. Our study provides a predictive framework for identifying high-risk patients and highlights mechanistically grounded compounds for potential irAE mitigation.

27 November 2024 in IET Systems Biology
Verified
Journal Article
Open access
XYXi Yong
Xi Yong
XHXuerui Hu
Xuerui Hu
TKTengyao Kang
Tengyao Kang
YDYanpiao Deng
Yanpiao Deng
SLSixuan Li
Sixuan Li
JLJingdong Li
Jingdong Li
Abdominal aortic aneurysm (AAA) is a severe vascular condition, marked by the progressive dilation of the abdominal aorta, leading to rupture if untreated. The objective of this study was to identify key biomarkers and decipher the immune mechanisms underlying AAA utilising multi‐omics data analysis and machine learning techniques. Single‐cell RNA sequencing disclosed a heightened presence of macrophages and CD8‐positive alpha‐beta T cells in AAA, highlighting their critical role in disease pathogenesis. Analysis of cell–cell communication highlighted augmented interactions between macrophages and dendritic cells derived from monocytes. Enrichment analysis of differential expression gene indicated substantial involvement of immune and metabolic pathways in AAA pathogenesis. Machine learning techniques identified CCR7 and CBX6 as key candidate biomarkers. In AAA, CCR7 expression is upregulated, whereas CBX6 expression is downregulated, both showing significant correlations with immune cell infiltration. These findings provide valuable insights into the molecular mechanisms underlying AAA and suggest potential biomarkers for diagnosis and therapeutic intervention.

22 September 2026 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
QYQin Yang
Qin Yang
XHXuerui Hu
Xuerui Hu
SYShihong Yu
Shihong Yu
TZTingjun Zhang
Tingjun Zhang
QZQirong Zhu
Qirong Zhu
XYXi Yong✉
Xi Yong✉
Introduction: Early identification of cirrhosis among patients with hepatitis is important for timely risk stratification and clinical management, yet conventional non-invasive scores such as the fibrosis-4 index (FIB-4) and the aspartate aminotransferase-to-platelet ratio index (APRI) may provide limited discrimination. In clinical datasets, missingness patterns may also carry predictive information, but their value for cirrhosis identification remains insufficiently investigated. Methods: We included 672 individuals, comprising 334 patients with hepatitis and 338 patients with cirrhosis, and randomly divided them into training and testing sets at in 8:2 ratio. FIB-4, APRI and multiple machine-learning models were developed using routinely available laboratory parameters; missing values were handled by median imputation, and binary missingness indicators were incorporated into selected models. Results: Machine-learning models showed better discriminatory performance than conventional scores. The Extra Trees model incorporating missingness indicators (ET + indicator) achieved the highest AUC (0.841), whereas the support vector machine model incorporating missingness indicators (SVM + indicator) achieved the highest AUPRC (0.813). By contrast, FIB-4 and APRI had AUC values of 0.537 and 0.519, respectively. Incorporating missingness indicators further improved the performance of ET, SVM and HGB models, and reducing the ET + indicator threshold from 0.50 to 0.42 increased sensitivity from 0.765 to 0.882. Discussion: Missingness-aware machine-learning models based on routine laboratory parameters may improve hepatitis-to-cirrhosis discrimination and support risk stratification in real-world screening settings.

5 September 2026 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
SYSha Yang
Sha Yang
LLLiping Liao
Liping Liao
QYQin Yang
Qin Yang
TXTianqin Xia
Tianqin Xia
SQShihan Qin
Shihan Qin
ZXzhengmin xu
zhengmin xu